| |
 |
|
| Science Advisor |
| Phone |
877-783-6728 |
| Fax |
877-259-0061 |
| Address |
|
| Website |
www.StemSave.com |
|
| |
| Dr. Jeremy J. Mao, DDS, Ph.D is an Oral Surgeon and the
Director of the Tissue Engineering and Regenerative Medicine Laboratory
(TERML) at Columbia University, as well as a Professor of Dental
Medicine and Biomedical Engineering at the University. Dr. Mao has
published over 300 scientific papers, book chapters, conference
proceedings and other articles in the areas of tissue engineering, stem
cells and regenerative medicine. He also serves on the editorial boards
of several scientific journals, including Tissue Engineering and the
Journal of Biomedical Material Research and has served on the editorial
boards of Stem Cells and Development, Medical Engineering and Physics
and Frontiers of Bioscience. Dr. Mao holds numerous patents in the
areas of stem cells, tissue engineering and regenerative medicine and
is a standing member of the Musculoskeletal Tissue Engineering Study
Section of the NIH. In addition to serving as a review panelist for the
NIH, Dr. Mao’s scientific expertise has also been sought on a regular
basis by NSF and the US Army, as well as many other significant
grant-review panels in over 18 countries. |
| |
|
 |
|
| Science Advisor |
| Phone |
877-783-6728 |
| Fax |
877-259-0061 |
| Address |
|
| Website |
www.StemSave.com |
|
| |
|
Gordana Vunjak-Novakovic, PhD is a Professor of Biomedical Engineering
at Columbia University, where she directs the Laboratory for Stem Cells and
Tissue Engineering, and holds appointments at the Department of Surgery and the
College of Dental Medicine. She received her B.S., S.M. and Ph.D from the
University of Belgrade (all in chemical engineering), and was a Fulbright
fellow at MIT in 1986-87. Prior to joining Columbia, Gordana was with the
University of Belgrade, MIT and Tufts University. She co-directs the NIH Tissue
Engineering Resource Center. Gordana published 235 peer-reviewed articles, two
books and 25 patents, and gave 150 invited lectures. She is a frequent advisor
to governmental organizations on tissue engineering and regenerative medicine,
and the chair of her NIH study section. In 2002, she was elected a Fellow of
the American Institute for Medical and Biological Engineering. In 2007, she
gave the Director’ lecture at the NIH, as the first woman engineer to receive
this distinction. In 2008, she was inducted into the Women in Technology International Hall of Fame “for
developing biological substitutes to restore, maintain or improve tissue
function”. |
| |
|
 |
|
| Science Advisor |
| Phone |
877-530-9581 |
| Fax |
877-259-0061 |
| Address |
|
| Website |
www.StemSave.com |
|
| |
| David A Matzilevich, MD, PhD is a founder and director of NECTAR (New England Cellular Therapies and Applied Research) where his work focuses on stem cell based therapeutic approaches. Prior to joining NECTAR, Dr. Matzilevich was a faculty member at McLean Hospital and Harvard Medical School. His worked there involved identification of molecular endophenotypes and susceptibility genes involved in the pathogenesis of Schizophrenia and Bipolar Disorder. Dr. Matzilevich received his MD, PhD from the Imperial College of Science, Technology and Medicine in London, UK. Following his studies in London, Dr. Matzilevich received a fellowship in the Department of Pathology at Tufts Medical School in Boston and went on to the University of Texas Medical Center at Houston in the Department of Neuroscience and the Keck Center for Neurology and Neurosurgery where he worked on the use of adult stem cells for the treatment of neurological disorders. Dr. Matzilevich is currently involved in several clinical trials using adult stem cells for treating neurological disorders. Dr. Matzilevich lectures extensively on stem cells, holds several patents and has published over 30 peer reviewed articles and papers. Dr. Matzilevich appears frequently on TV, radio, industry and scientific journals as well as mainstream print media as an acknowledged stem cell expert. |
| |
|